Monthly shot tested to curb opioid cravings in High-Risk adults

NCT ID NCT04995029

Completed Disease control Sponsor: Indivior Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested two different monthly doses of a long-acting buprenorphine injection to help control opioid addiction. It involved 785 adults with moderate-to-severe opioid use disorder who were considered high-risk users. The main goal was to see which monthly dose was better at helping participants stay off opioids over several months.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Accel Research Sites- Lakeland Clinical Research Unit

Lakeland, Florida, 33803, United States
Alpine Research Organization

Clinton, Utah, 84015, United States
Artemis Institute for Clinical Research

San Diego, California, 92103, United States
Asclepes Research Centers

Panorama City, California, 91402, United States
Bay Pines VA Healthcare System

Bay Pines, Florida, 33744, United States
Behavioral Clinical Research, Inc

Miami Lakes, Florida, 33016, United States
Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States
Carolina Medical Research, LLC

Clinton, South Carolina, 29325, United States
Carolina Medical Research, LLC

Greenville, South Carolina, 29607, United States
Center For Emotional Fitness

Cherry Hill, New Jersey, 08002, United States
Centre for Addiction and Mental Health

Toronto, Ontario, M6J 1H4, Canada
Clinical Neuroscience Solutions, Inc

Orlando, Florida, 32801, United States
Clinical Research Associates of Central PA

Altoona, Pennsylvania, 16602, United States
Collaborative Neuroscience Network, LLC

Garden Grove, California, 92845, United States
David Weitzman

Myrtle Beach, South Carolina, 29577, United States
Duke Hospital

Durham, North Carolina, 27705, United States
Hassman Research Institute

Berlin, New Jersey, 08009, United States
ICAHN School of Medicine at Mount Sinai

New York, New York, 10029, United States
Innovative Clinical Research Inc.

North Miami, Florida, 33161, United States
Insite Clinical Research

DeSoto, Texas, 75115, United States
Midwest Clinical Research

Dayton, Ohio, 45417, United States
Monroe Biomedical Research

Monroe, North Carolina, 28112, United States
Pahl Pharmaceutical Professionals LLC

Oklahoma City, Oklahoma, 73112, United States
Prisma Health ITOR Research Pharmacy

Greenville, South Carolina, 29605, United States
Progressive Clinical Research

Bountiful, Utah, 84010, United States
SP Research, PLLC

Oklahoma City, Oklahoma, 73112, United States
Sarkis Clinical Trials

Gainesville, Florida, 32607, United States
Today Clinical Research

Oklahoma City, Oklahoma, 73120, United States
Unity Clinical Research

Oklahoma City, Oklahoma, 73118, United States

Conditions

Explore the condition pages connected to this study.

MODERATE TO SEVERE OPIOID USE DISORDER